Human clinical study shows the use of Neumentix™ Phenolic Complex K110-42 has benefits for cognitive performance in adults

摘要

Kemin is excited to announce the findings of a new human clinical study showing that the use of Neumentix'" Phenolic Complex K110-42, a patent-pending spearmint extract containing a proprietary phenolic complex, helps to improve cognitive performance in older adults with age- associated memory impairment. These study results will be presented by Biofortis, a Merieux NutriSciences company, in a poster session at Experimental Biology 2015 sponsored by the American Society for Nutrition. "We are very excited to be able to share the results from our study with attendees at Experimental Biology," stated DeAnn Liska, Senior Director of Nutrition and Scientific Affairs at Biofortis. "The study was significant in that it suggested this proprietary ingredient may have benefits for cognitive health and performance using a number of validated measurements." The study, "Effects of a Proprietary Spearmint Extract on Cognitive Function and Tolerance Parameters in Men and Women with Age-Associated Memory Impairment" assessed cognitive health and performance using the Cognitive Drug Research (CDR) battery, a well-established, standardized and validated testing tool that has been used in numerous published clinical studies. In addition to CDR, subjects also completed several validated clinical questionnaires including the Profile of Mood States (POMS) and the Leeds Sleep Evaluation Questionnaire (LSEQ).